CD73 inhibitors
US11576922B2 · kind B2 · utility
0Cited by
3References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2021 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Aug 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6558
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.